Peter Lynch fit · Growth at a reasonable price (GARP)
Is Anbio Biotechnology Class A Ordinary Shares (NNNN) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria — growth too low or price too high.
15/100
FNot a fit
3/6 criteria passed
Peter Lynch's Criteria, Applied to NNNN
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key-48.3%
Revenue CAGR ≥ 10%
-24.9%
Net margin > 0
37.5%
How NNNN Scores on Other Strategies
Live Financial Snapshot
Market cap
$278.27M
P/E (TTM)
171.9x
ROIC (TTM)
21.48%
Gross margin
87.06%
Other Peter Lynch fit reports
Frequently Asked Questions
What is NNNN's Peter Lynch fit score?
NNNN scores 15/100 on our Peter Lynch fit engine — grade F. Does not fit Lynch's GARP criteria — growth too low or price too high.
Does Peter Lynch actually own NNNN?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends NNNN.
How often is this score updated?
NNNN's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends NNNN.